View Author
vaccination vaccine hepatitis infection study hepatitis b health varicella patient pertussis disease group screening model strategy country treatment children result neuropathy evaluation prevention thalidomide population effect coverage analysis table healthcare acellular immunization myeloma number program antibody bortezomib adult varicella vaccination virus cost-effectiveness value europe whole-cell european hepatitis c review benefit liver acellular vaccine intervention subject university incidence programmes diphtheria prevalence travel figure ratio zoster individual immunity saving trial factor damme varicella vaccine estimate adolescent dtpa ‑ipv tetanus region cancer price history vaccination programs month impact assumption liver cancer
10 Most Recent Publications
|
The state of hepatitis B and C in Europe: Report from the hepatitis B and C summit conference
(Article)
Hatzakis, A. Wait, S. Esteban, R. Goldberg, D. Gore, C. Lok, A.S.F. Manns, M. Marcellin, P. Papatheodoridis, G. Peterle, A. Prati, D. Piorkowsky, N. Bruix, J. Rizzetto, M. Roudot-Thoraval, F. Soriano, V. Thomas, H.C. Thursz, M. Valla, D.C. Damme, P. van Veldhuizen, I.K. Wedemeyer, H. Wiessing, L. Buti, M. Zanetti, A.R. Janssen, H.L.A. Carballo, M. Cavaleri, M. Colombo, M.G. Delarocque-Astagneau, E. Dusheiko, G. Esmat, G. |
2011-09-01
|
|
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
(Article)
Delforge, M. Bladé, J. Dimopoulos, M.A. Facon, T. Kropff, M. Ludwig, H. Palumbo, A. Damme, P. van San-Miguel, J-F. Sonneveld, P. |
2010-11-01
|
|
Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival
(Article)
Damme, P. van Hoecke, A. van Lambrechts, D. Vanacker, P. Bogaert, E. Swieten, J.C. van Carmeliet, P. Bosch, L. van den Robberecht, W. |
2008-04-07
|
|
Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccines
(Article)
Theeten, H. Rümke, H. Hoppener, F.J.P. Vilatimó, R. Narejos, S. Damme, P. van Hoet, B. |
2007-11-01
|
|
Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature. The Authors' Reply.
(Article)
Thiry, N. Beutels, P. Damme, P. van Doorslaer, E.K.A. van |
2004-01-01
|
|
Methodological issues and new developments in the economic evaluation of vaccines
(Article)
Beutels, P. Doorslaer, E.K.A. van Damme, P. van Hall, J. |
2003-10-01
|
|
Economic Evaluations of Varicella Vaccination Programmes: A Review of the Literature
(Article)
Thiry, N. Beutels, P. Damme, P. van Doorslaer, E.K.A. van |
2003-01-01
|
|
Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany
(Article)
Tormans, G. Clara, R. Doorslaer, E.K.A. van Damme, P. van |
1998-05-28
|
|
Hepatitis B prevention in Europe: a preliminary economic evaluation
(Article)
Damme, P. van Tormans, G. Beutels, P. Doorslaer, E.K.A. van |
1995-01-01
|
|
Cost-effectiveness analysis of vaccination against hepatitus A in travellers
(Article)
Doorslaer, E.K.A. van Tormans, G. Damme, P. van |
1994-12-01
|
